Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
It is not an FDA-approved drug for systemic therapeutic use
American Chemical Society
Glutathione is a natural reducing agent in the body that can effectively remove free radicals in the body and restore protein activity
Just focus on the big things and then, once you get there, you can focus on optimization and experimentation with the little things
Note: While TB-500 is often discussed as thymus-derived, it is a synthetic fragment not naturally produced in the thymus